Daily Technology News

Technology News and Press Release Distribution Services

About US | Contact Us

Home | Technology News | Submit Press Release | Submit RSS Feed
Unlimited Press Release Distribution
Press release distribution service

IT News Media

ComputerWeekly
CIO News
PC World
MacWorld
InfoWorld
Tech Republic
Wall Street Journal Digital
ZDNet
Submit press release to these Tech media distribution list.

Technology News Releases

Vaccine Adjuvants Market by Type, End-use Industry, and Region – Global Forecast to 2021 (At a CAGR of 10.5 %)

 



(IT-NEWSWIRE.COM, April 06, 2021 ) This report aims to provide insights into the global vaccine adjuvants market. It provides valuable information on the product type, route of administration, disease type, applications, and application categories in the market. Furthermore, the information for these segments, by region, is also presented in this report.

According to the new market research report “ Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category – Forecasts to 2021″, published by MarketsandMarkets™, the global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%.

Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Key Factors Driving Market Growth:

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

Revenue Growth Analysis:

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%.

Don’t miss out on business opportunities in vaccine adjuvants market

On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016. The adjuvant emulsions segment, on the other hand, is projected to grow at the highest CAGR during the forecast period. This market is mainly driven by factors such as rising prevalence of diseases such as allergy, cancer, and HIV/AIDS; growing demand for advanced treatment options, and development of improved vaccine immunization.

Browse in-depth TOC on “Vaccine Adjuvants Market”

90 Tables
42 Figures
156 Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

On the basis of route of administration, the market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. Factors such as the rapidly growing geriatric population and vaccines for improved immunization are propelling the growth of this market. Rise in collaborations and acquisitions by private organizations and increased funding by government bodies for research and development are also expected to drive market growth.

On the basis of disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer, and others. The infectious diseases segment is expected to account for the largest share of the global market in 2016. Factors such as high prevalence of infectious diseases, government & company initiatives, and high prevalence of cancer cases are expected to drive market growth in the coming years.

On the basis of applications, the market is segmented into research and commercial applications. The research applications segment is expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by factors such as ongoing research projects on new adjuvants, increasing initiatives by government bodies and companies, growing usage of many vaccine adjuvants commercially, and increasing incidences of zoonotic diseases.

Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

Key Market Players

The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

MarketsandMarkets™

Mr. Aashish Mehra

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com



Technology News By Sector
  • Application Development
  • Big Data
  • Desktops
  • Cloud Computing
  • Data Centers
  • Mobile Computing
  • OS
  • Open Source
  • Security
  • Virtualization
  • 
    
    

     Sign-Up To Our Free Newsletter!  
    IT-NewsWire Newsletter
     


    
    
    
    
    Technology Marketplace

    Free Information Technology Magazines, Downloads
    Get free tech publications including magazines and white papers
    Amazon, Inc News Headlines
    Read breaking news about Amazon.com as reported by TV news anchors and summaries news articles from New York Times

    Free Computer Security Magazines
    Download or subscribe to latest IT Security publications -- free of charge.

    Microsoft News
    Microsoft financial and at Work: read news about MSFT hardware, software and services.
    Submit RSS News Feed.
    Have your feed on news, products or services displayed under this marketpalce. The feed is also displayed on a full page and updated daily. Add RSS feed Now!



    Press release distribution services: Submit press release to major media. Unlimited press release service

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.

    IT-Newswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2013 GroupWeb Media LLC. All Rights Reserved.


    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    IT-NewsWire.Com - Newswire and Press Release service of GroupWeb Media LLC